Tapewire

Nasdaq · USD

ASTH

Astrana Health, Inc.

Export transactions ↓
Tapewire entity
4538
SEC CIK
0001083446
Parsed reports
385

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 08, 2022 Filed Dec 12, 2022 23:50 UTC
Sim Kenneth T.Director · Executive Chairman
Exercise / conversionCommon Stock 51,445 $10.00 $514,450.00
Disclosure

SEC source: 0001250853-22-000121 · primary_doc.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 243,272

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 07, 2022 Filed Dec 9, 2022 23:43 UTC
Lam Thomas S.Director · President and Co-CEO
Sim Kenneth T.Director · Executive Chairman
Young Albert WaiChowChief Administrative Officer
Exercise / conversionWarrants to purchase Common Stock · Derivative 52,262.84 Not disclosed Strike: $11.00 Not disclosed
Disclosure

SEC source: 0001250853-22-000120 · primary_doc.xml · derivative · entry 4

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 52,262.84 shares

Expires 2022-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into certain securities of the Issuer and other consideration, including (i) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share and (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share.

Read SEC document
December 07, 2022 Filed Dec 9, 2022 23:43 UTC
Lam Thomas S.Director · President and Co-CEO
Sim Kenneth T.Director · Executive Chairman
Young Albert WaiChowChief Administrative Officer
Exercise / conversionWarrants to purchase Common Stock · Derivative 55,337.13 Not disclosed Strike: $10.00 Not disclosed
Disclosure

SEC source: 0001250853-22-000120 · primary_doc.xml · derivative · entry 3

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 55,337.13 shares

Expires 2022-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into certain securities of the Issuer and other consideration, including (i) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share and (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share.

Read SEC document
December 07, 2022 Filed Dec 9, 2022 23:43 UTC
Lam Thomas S.Director · President and Co-CEO
Sim Kenneth T.Director · Executive Chairman
Young Albert WaiChowChief Administrative Officer
Exercise / conversionCommon Stock 52,262 $11.00 $574,882.00
Disclosure

SEC source: 0001250853-22-000120 · primary_doc.xml · nonDerivative · entry 2

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,299,259

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares are owned directly by the Reporting Person, and indirectly by Kenneth Sim, Thomas Lam, and Albert Young, each of whom is a director, officer and shareholder of the Reporting Person.

Read SEC document
December 07, 2022 Filed Dec 9, 2022 23:43 UTC
Lam Thomas S.Director · President and Co-CEO
Sim Kenneth T.Director · Executive Chairman
Young Albert WaiChowChief Administrative Officer
Exercise / conversionCommon Stock 55,337 $10.00 $553,370.00
Disclosure

SEC source: 0001250853-22-000120 · primary_doc.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,246,997

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares are owned directly by the Reporting Person, and indirectly by Kenneth Sim, Thomas Lam, and Albert Young, each of whom is a director, officer and shareholder of the Reporting Person.

Read SEC document
December 05, 2022 Filed Dec 8, 2022 00:04 UTC
Lam Thomas S.Director · President and Co-CEO
Exercise / conversionWarrants to purchase Common Stock · Derivative 48,585.84 Not disclosed Strike: $11.00 Not disclosed
Disclosure

SEC source: 0001250853-22-000118 · primary_doc.xml · derivative · entry 6

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 48,585.84 shares

Expires 2022-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,563,763 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share , (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 173,751.48 shares of common stock of the Issuer).

Read SEC document
December 05, 2022 Filed Dec 8, 2022 00:04 UTC
Lam Thomas S.Director · President and Co-CEO
Exercise / conversionWarrants to purchase Common Stock · Derivative 51,442.83 Not disclosed Strike: $10.00 Not disclosed
Disclosure

SEC source: 0001250853-22-000118 · primary_doc.xml · derivative · entry 5

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 51,442.83 shares

Expires 2022-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,563,763 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share , (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 173,751.48 shares of common stock of the Issuer).

Read SEC document
December 05, 2022 Filed Dec 8, 2022 00:04 UTC
Lam Thomas S.Director · President and Co-CEO
Exercise / conversionCommon Stock 48,585 $11.00 $534,435.00
Disclosure

SEC source: 0001250853-22-000118 · primary_doc.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,855

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 05, 2022 Filed Dec 8, 2022 00:04 UTC
Lam Thomas S.Director · President and Co-CEO
Exercise / conversionCommon Stock 51,443 $10.00 $514,430.00
Disclosure

SEC source: 0001250853-22-000118 · primary_doc.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 243,270

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 02, 2022 Filed Dec 7, 2022 02:43 UTC OtherCommon Stock 984,042 $0.00 $0.00
Disclosure

SEC source: 0001250853-22-000117 · primary_doc.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,191,660

F1 · kind: The Reporting Person distributed these shares as an in-kind dividend to its shareholders.

Read SEC document
December 02, 2022 Filed Dec 7, 2022 02:40 UTC
Young Albert WaiChowChief Administrative Officer
OtherCommon Stock 19,506 $0.00 $0.00
Disclosure

SEC source: 0001250853-22-000116 · primary_doc.xml · nonDerivative · entry 2

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,184,749

F3 · kind: Represents the receipt of shares of the issuer pursuant to a pro rata in-kind distribution by Allied, of which the Reporting Person is a director, officer and shareholder.

Read SEC document
December 02, 2022 Filed Dec 7, 2022 02:40 UTC
Young Albert WaiChowChief Administrative Officer
OtherCommon Stock 984,042 $0.00 $0.00
Disclosure

SEC source: 0001250853-22-000116 · primary_doc.xml · nonDerivative · entry 1

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Allied Physicians of California, a Professional Medical Corporation

Disclosed balance after: 10,191,660

F1 · kind: Allied Physicians of California, A Profession Medical Corporation ("Allied"), of which the Reporting Person is a director, officer and shareholder, distributed these shares as an in-kind dividend to its shareholders.

F2 · balance_after: These securities are beneficially owned by Allied, of which the Reporting Person is a director, officer and shareholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
December 02, 2022 Filed Dec 7, 2022 02:36 UTC
Lam Thomas S.Director · President and Co-CEO
OtherCommon Stock 37,439 $0.00 $0.00
Disclosure

SEC source: 0001250853-22-000115 · primary_doc.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 1,107,474

F3 · kind: Represents the receipt of shares of the issuer pursuant to a pro rata in-kind distribution by Allied, of which the Reporting Person is a director, officer and shareholder.

Read SEC document
December 02, 2022 Filed Dec 7, 2022 02:36 UTC
Lam Thomas S.Director · President and Co-CEO
OtherCommon Stock 984,042 $0.00 $0.00
Disclosure

SEC source: 0001250853-22-000115 · primary_doc.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Allied Physicians of California, A Professional Medical Corporation

Disclosed balance after: 10,191,660

F1 · kind: Allied Physicians of California, A Profession Medical Corporation ("Allied"), of which the Reporting Person is a director, officer and shareholder, distributed these shares as an in-kind dividend to its shareholders.

F2 · balance_after: These securities are beneficially owned by Allied, of which the Reporting Person is a director, officer and shareholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
December 02, 2022 Filed Dec 7, 2022 02:29 UTC
Sim Kenneth T.Director · Executive Chairman
OtherCommon Stock 37,439 $0.00 $0.00
Disclosure

SEC source: 0001250853-22-000114 · primary_doc.xml · nonDerivative · entry 2

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Kenneth T & Simone S Sim Family Trust

Disclosed balance after: 520,117

F3 · kind: Represents the receipt of shares of the issuer pursuant to a pro rata in-kind distribution by Allied, of which the Reporting Person is a director, officer and shareholder.

Read SEC document
December 02, 2022 Filed Dec 7, 2022 02:29 UTC
Sim Kenneth T.Director · Executive Chairman
OtherCommon Stock 984,042 $0.00 $0.00
Disclosure

SEC source: 0001250853-22-000114 · primary_doc.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Allied Physicians of California, A Professional Medical Corporation

Disclosed balance after: 10,191,660

F1 · kind: Allied Physicians of California, A Profession Medical Corporation (Allied), of which the Reporting Person is a director, officer and shareholder, distributed these shares as an in-kind dividend to its shareholders.

F2 · balance_after: These securities are beneficially owned by Allied, of which the Reporting Person is a director, officer and shareholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
November 29, 2022 Filed Dec 1, 2022 20:54 UTC
Young Albert WaiChowChief Administrative Officer
Exercise / conversionWarrants to purchase Common Stock · Derivative 26,828.01 Not disclosed Strike: $11.00 Not disclosed
Disclosure

SEC source: 0001250853-22-000095 · primary_doc.xml · derivative · entry 5

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,828.01 shares

Expires 2022-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 854,207 shares of common stock of the Issuer, (ii) a warrant to purchase 26,828.01 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 28,406.13 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 94,911.80 shares of common stock of the Issuer).

Read SEC document
November 29, 2022 Filed Dec 1, 2022 20:54 UTC
Young Albert WaiChowChief Administrative Officer
Exercise / conversionWarrants to purchase Common Stock · Derivative 28,406.13 Not disclosed Strike: $10.00 Not disclosed
Disclosure

SEC source: 0001250853-22-000095 · primary_doc.xml · derivative · entry 4

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28,406.13 shares

Expires 2022-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 854,207 shares of common stock of the Issuer, (ii) a warrant to purchase 26,828.01 shares of common stock of the Issuer at an exercise price of $11.00 per share, (iii) a warrant to purchase 28,406.13 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 94,911.80 shares of common stock of the Issuer).

Read SEC document
November 29, 2022 Filed Dec 1, 2022 20:54 UTC
Young Albert WaiChowChief Administrative Officer
Exercise / conversionCommon Stock 26,828 $11.00 $295,108.00
Disclosure

SEC source: 0001250853-22-000095 · primary_doc.xml · nonDerivative · entry 2

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,165,243

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 29, 2022 Filed Dec 1, 2022 20:54 UTC
Young Albert WaiChowChief Administrative Officer
Exercise / conversionCommon Stock 28,406 $10.00 $284,060.00
Disclosure

SEC source: 0001250853-22-000095 · primary_doc.xml · nonDerivative · entry 1

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,138,415

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 04, 2022 Filed Nov 4, 2022 23:39 UTC
Sim BrandonCo-Chief Executive Officer
GrantCommon Stock 20,320 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-115009 · tm2229819d1_4.xml · nonDerivative · entry 2

Sim Brandon · CIK 0001813532 · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 522,567

F2 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, vesting of the restricted shares is based on achievement of pre-established financial performance goals on or before December 31, 2024.

Read SEC document
November 04, 2022 Filed Nov 4, 2022 23:39 UTC
Sim BrandonCo-Chief Executive Officer
GrantCommon Stock 11,113 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-115009 · tm2229819d1_4.xml · nonDerivative · entry 1

Sim Brandon · CIK 0001813532 · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 502,247

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the following dates, the shares of restricted stock shall vest in four equal annual installments commencing on the first anniversary of June 27, 2022.

Read SEC document
September 27, 2022 Filed Dec 2, 2022 23:46 UTC GiftCommon Stock 392,816 $0.00 $0.00
Disclosure

SEC source: 0001250853-22-000098 · primary_doc.xml · nonDerivative · entry 2

Sim Brandon · CIK 0001813532 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Brandon Sim 2020 Irrevocable Trust

Disclosed balance after: 392,816

F2 · balance_after: These securities are held by the Brandon Sim 2020 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 27, 2022 Filed Dec 2, 2022 23:41 UTC
Sim Kenneth T.Director · Executive Chairman
GiftCommon Stock 392,816 $0.00 $0.00
Disclosure

SEC source: 0001250853-22-000097 · primary_doc.xml · nonDerivative · entry 3

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By wife

Disclosed balance after: 0

F3 · balance_after: On September 17, 2020, the spouse of the Reporting Person contributed 564,706 shares of AMEH common stock to a grantor retained annuity trust (the SS GRAT) for the benefit of herself and her children. On September 27, 2021 45,838 shares were distributed from the SS GRAT to the Family Trust in satisfaction of an annuity obligation. On September 22, 2022, 126,051 shares were distributed from the SS GRAT to the Family Trust in satisfaction of an annuity obligation. Upon termination of the trust on September 27, 2022, the remaining 392,816 shares were transferred to the children of the Reporting Person. The 171,889 shares previously distributed to the Family Trust will continue to be reported as indirectly owned by the Reporting Person.

Read SEC document
September 27, 2022 Filed Dec 2, 2022 23:41 UTC
Sim Kenneth T.Director · Executive Chairman
GiftCommon Stock 392,816 $0.00 $0.00
Disclosure

SEC source: 0001250853-22-000097 · primary_doc.xml · nonDerivative · entry 2

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By grantor retained annuity trust

Disclosed balance after: 0

F2 · balance_after: On September 17, 2020, the Reporting Person contributed 564,706 shares of AMEH common stock to a grantor retained annuity trust (the KS GRAT) for the benefit of himself and his children. On September 27, 2021 45,838 shares were distributed from the KS GRAT to the Family Trust in satisfaction of an annuity obligation. On September 22, 2022, 126,051 shares were distributed from the KS GRAT to the Family Trust in satisfaction of an annuity obligation. Upon termination of the trust on September 27, 2022, the remaining 392,816 shares were transferred to the children of the Reporting Person. The 171,889 shares previously distributed to the Family Trust will continue to be reported as indirectly owned by the Reporting Person.

Read SEC document
September 27, 2022 Filed Dec 2, 2022 23:30 UTC
Lam Thomas S.Director · President and Co-CEO
GiftCommon Stock 383,764 $0.00 $0.00
Disclosure

SEC source: 0001250853-22-000096 · primary_doc.xml · nonDerivative · entry 3

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By wife

Disclosed balance after: 0

F3 · balance_after: On September 17, 2020, the spouse of the Reporting Person contributed 564, 691 shares of AMEH common stock to a grantor retained annuity trust (the JL GRAT) for the benefit of herself and her children. On September 27, 2021 45,836 shares were distributed from the JL GRAT to the Family Trust in satisfaction of an annuity obligation. On September 22, 2022, 135,090 shares were distributed from the JL GRAT to the Family Trust in satisfaction of an annuity obligation. Upon termination of the trust on September 27, 2022, the remaining 383,764 shares were transferred to the children of the Reporting Person. The 180,926 shares previously distributed to the Family Trust will continue to be reported as indirectly owned by the Reporting Person.

Read SEC document
September 27, 2022 Filed Dec 2, 2022 23:30 UTC
Lam Thomas S.Director · President and Co-CEO
GiftCommon Stock 383,764 $0.00 $0.00
Disclosure

SEC source: 0001250853-22-000096 · primary_doc.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By grantor retained annuity trust

Disclosed balance after: 0

F2 · balance_after: On September 17, 2020, the Reporting Person contributed 564,691 shares of AMEH common stock to a grantor retained annuity trust (the TL GRAT) for the benefit of himself and his children. On September 27, 2021 45,836 shares were distributed from the TL GRAT to the Family Trust in satisfaction of an annuity obligation. On September 22, 2022, 135,090 shares were distributed from the TL GRAT to the Family Trust in satisfaction of an annuity obligation. Upon termination of the trust on September 27, 2022, the remaining 383,764 shares were transferred to the children of the Reporting Person. The 180,926 shares previously distributed to the Family Trust will continue to be reported as indirectly owned by the Reporting Person.

Read SEC document
June 27, 2022 Filed Jun 30, 2022 01:36 UTC
Sim BrandonCo- Chief Executive Officer
GrantCommon Stock 198,511 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-075935 · tm2220100-1_4seq1.xml · nonDerivative · entry 2

Sim Brandon · CIK 0001813532 · Co- Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 491,134

F2 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, vesting of the restricted shares is based on achievement of pre-established financial performance goals on or before December 31, 2024.

Read SEC document
June 27, 2022 Filed Jun 30, 2022 01:36 UTC
Sim BrandonCo- Chief Executive Officer
GrantCommon Stock 108,560 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-075935 · tm2220100-1_4seq1.xml · nonDerivative · entry 1

Sim Brandon · CIK 0001813532 · Co- Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,623

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the following dates, the shares of restricted stock shall vest in four equal annual installments commencing on the first anniversary of June 27, 2022.

Read SEC document
June 17, 2022 Filed Jun 18, 2022 00:26 UTC
Dong LindaDirector
SaleCommon Stock 250,000 $37.00 $9,250,000.00
Disclosure

SEC source: 0001104659-22-072514 · tm2218854d2_4.xml · nonDerivative · entry 1

Marsh Linda · CIK 0001765204 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Alliance Apex, LLC

Disclosed balance after: 270,081

F1 · ownership.nature: These shares are owned directly by Alliance Apex, LLC, of which Reporting Person is a member and the sole manager. Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 17, 2022 Filed Jun 18, 2022 00:24 UTC PurchaseCommon Stock 250,000 $37.00 $9,250,000.00
Disclosure

SEC source: 0001104659-22-072513 · tm2218854d1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,175,702

F1 · acquired: These shares were purchased from Alliance Apex, LLC.

Read SEC document
March 31, 2022 Filed Apr 5, 2022 01:35 UTC
Young Albert WaiChowChief Administrative Officer
Tax withholdingCommon Stock 256 $48.47 $12,408.32
Disclosure

SEC source: 0001250853-22-000052 · primary_doc.xml · nonDerivative · entry 1

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,110,009

F1 · kind: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award which vested on March 31, 2022.

Read SEC document
March 31, 2022 Filed Apr 5, 2022 01:39 UTC
Chin EricChief Financial Officer
Tax withholdingCommon Stock 469 $48.47 $22,732.43
Disclosure

SEC source: 0001250853-22-000053 · primary_doc.xml · nonDerivative · entry 1

Chin Eric · CIK 0001751197 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,844

F1 · kind: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award which vested on March 31, 2022.

Read SEC document
March 03, 2022 Filed Dec 2, 2022 23:30 UTC
Lam Thomas S.Director · President and Co-CEO
GiftCommon Stock 200,000 $0.00 $0.00
Disclosure

SEC source: 0001250853-22-000096 · primary_doc.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 799,855

F1 · balance_after: These securities are held by The Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002 (the Family Trust). The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
February 25, 2022 Filed Dec 2, 2022 23:46 UTC GiftCommon Stock 258,824 $0.00 $0.00
Disclosure

SEC source: 0001250853-22-000098 · primary_doc.xml · nonDerivative · entry 1

Sim Brandon · CIK 0001813532 · Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Sim Family Irrevocable Trust 2021

Disclosed balance after: 258,824

F1 · balance_after: These securities are held by the Sim Family Irrevocable Trust 2021. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
February 25, 2022 Filed Dec 2, 2022 23:41 UTC
Sim Kenneth T.Director · Executive Chairman
GiftCommon Stock 258,824 $0.00 $0.00
Disclosure

SEC source: 0001250853-22-000097 · primary_doc.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Kenneth T & Simone S Sim Family Trust

Disclosed balance after: 230,576

F1 · balance_after: These securities are held by the Kenneth T & Simone S Sim Family Trust U/A dated 11/07/2013 (the Family Trust). The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
February 03, 2022 Filed Feb 7, 2022 21:14 UTC
Chin EricChief Financial Officer
Tax withholdingCommon Stock 2,802 $50.71 $142,089.42
Disclosure

SEC source: 0001250853-22-000039 · primary_doc.xml · nonDerivative · entry 1

Chin Eric · CIK 0001751197 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,313

F1 · kind: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of certain restricted stock awards which vested on February 3, 2022.

Read SEC document
January 20, 2022 Filed Jan 24, 2022 21:24 UTC GrantStock Option (right to buy) · Derivative 8,500 $0.00 Strike: $53.01 $0.00
Disclosure

SEC source: 0001250853-22-000029 · primary_doc.xml · derivative · entry 1

Kitayama Mitchell W · CIK 0001333154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2025-01-18

F1 · derivative.exercise_date: The option vests in four equal quarterly installments from January 18, 2022.

Read SEC document
January 20, 2022 Filed Jan 24, 2022 16:00 UTC GrantStock Option (right to buy) · Derivative 8,500 $0.00 Strike: $53.01 $0.00
Disclosure

SEC source: 0001250853-22-000025 · primary_doc.xml · derivative · entry 1

BATES ERNEST A · CIK 0000946042 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2025-01-18

F1 · derivative.exercise_date: The option vests in four equal quarterly installments from January 18, 2022.

Read SEC document
January 20, 2022 Filed Jan 24, 2022 23:01 UTC
Dong LindaDirector
GrantStock Option (right to buy) · Derivative 8,500 $0.00 Strike: $53.01 $0.00
Disclosure

SEC source: 0001250853-22-000030 · primary_doc.xml · derivative · entry 1

Marsh Linda · CIK 0001765204 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2025-01-18

F1 · derivative.exercise_date: The option vests in four equal quarterly installments from January 18, 2022.

Read SEC document
January 20, 2022 Filed Jan 24, 2022 23:04 UTC GrantStock Option (right to buy) · Derivative 8,500 $0.00 Strike: $53.01 $0.00
Disclosure

SEC source: 0001250853-22-000031 · primary_doc.xml · derivative · entry 1

Mazdyasni Matthew · CIK 0001809915 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2025-01-18

F1 · derivative.exercise_date: The option vests in four equal quarterly installments from January 18, 2022.

Read SEC document
January 20, 2022 Filed Jan 24, 2022 21:18 UTC
Fawcett MarkDirector
GrantStock Option (right to buy) · Derivative 8,500 $0.00 Strike: $53.01 $0.00
Disclosure

SEC source: 0001250853-22-000028 · primary_doc.xml · derivative · entry 1

Fawcett Mark · CIK 0001664134 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2025-01-18

F1 · derivative.exercise_date: The option vests in four equal quarterly installments from January 18, 2022.

Read SEC document
January 20, 2022 Filed Jan 24, 2022 21:11 UTC GrantStock Option (right to buy) · Derivative 8,500 $0.00 Strike: $53.01 $0.00
Disclosure

SEC source: 0001250853-22-000027 · primary_doc.xml · derivative · entry 1

Eng Michael F. · CIK 0001725261 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2025-01-18

F1 · derivative.exercise_date: The option vests in four equal quarterly installments from January 18, 2022.

Read SEC document
January 20, 2022 Filed Jan 24, 2022 21:06 UTC
Chiang JohnDirector
GrantStock Option (right to buy) · Derivative 8,500 $0.00 Strike: $53.01 $0.00
Disclosure

SEC source: 0001250853-22-000026 · primary_doc.xml · derivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2025-01-18

F1 · derivative.exercise_date: The option vests in four equal quarterly installments from January 18, 2022.

Read SEC document
January 20, 2022 Filed Jan 24, 2022 20:55 UTC GrantStock Option (right to buy) · Derivative 8,500 $0.00 Strike: $53.01 $0.00
Disclosure

SEC source: 0001250853-22-000024 · primary_doc.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2025-01-18

F1 · derivative.exercise_date: The option vests in four equal quarterly installments from January 18, 2022.

Read SEC document
November 04, 2021 Filed Dec 30, 2021 23:49 UTC
Sim Kenneth T.Director · Executive Chairman
GiftCommon Stock 230,688 $0.00 $0.00
Disclosure

SEC source: 0001250853-21-000117 · primary_doc.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Kenneth T & Simone S Sim Family Trust

Disclosed balance after: 397,724

F1 · kind: On November 4, 2021, the Kenneth T & Simone S Sim Family Trust gifted 230,688 shares of AMEH common stock to a grantor retained annuity trust for the benefit of the Reporting Person's wife, who shares his household, and his children. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F2 · balance_after: These securities are held by the Kenneth T & Simone S Sim Family Trust U/A dated 11/07/2013. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F5 · balance_after: On November 4, 2021, the Kenneth T & Simone S Sim Family Trust contributed 230,688 shares of AMEH common stock to a grantor retained annuity trust for the benefit of the Reporting Person and his children. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
November 02, 2021 Filed Nov 5, 2021 00:25 UTC
Lam Thomas S.Director · President and Co-CEO
GrantStock Option (right to buy) · Derivative 29,502 $0.00 Strike: $71.45 $0.00
Disclosure

SEC source: 0001628280-21-021872 · wf-form4_163607193862764.xml · derivative · entry 6

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,502

Underlying: Common Stock · 29,502 shares

Expires 2026-11-02

F5 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the option shall vest in three equal annual installments commencing on the first anniversary of November 2, 2021.

Read SEC document
November 02, 2021 Filed Nov 5, 2021 00:25 UTC
Lam Thomas S.Director · President and Co-CEO
GrantCommon Stock 65,242 $0.00 $0.00
Disclosure

SEC source: 0001628280-21-021872 · wf-form4_163607193862764.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,827

Read SEC document
November 02, 2021 Filed Nov 5, 2021 00:16 UTC
Sim Kenneth T.Director · Executive Chairman
GrantStock Option (right to buy) · Derivative 29,502 $0.00 Strike: $71.45 $0.00
Disclosure

SEC source: 0001628280-21-021865 · wf-form4_163607138351398.xml · derivative · entry 7

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,502

Underlying: Common Stock · 29,502 shares

Expires 2026-11-02

F6 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the option shall vest in three equal annual installments commencing on the first anniversary of November 2, 2021.

Read SEC document
November 02, 2021 Filed Nov 5, 2021 00:16 UTC
Sim Kenneth T.Director · Executive Chairman
GrantCommon Stock 65,242 $0.00 $0.00
Disclosure

SEC source: 0001628280-21-021865 · wf-form4_163607138351398.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,827

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.